Consistent with previous results, under PE treatment, deficiency of GCN5 reduced cardiac hypertrophy marker expression at the mRNA and protein levels (Fig. 4B, Supplementary Fig. 2C). Here, KAT2A is linked to cardiac hypertrophy.